Latest News and Press Releases

NEW YORK, Oct. 31, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE MKT:NBS) ("NeoStem" or the "Company"), an emerging leader in the fast growing cell therapy market, today announced that Company...

NEW YORK, NY--(Marketwire - Oct 31, 2012) - Information Builders, a leader in business intelligence (BI) and analytics, information integrity, and integration solutions, today announced that iWay...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} OCTOPUS SECOND AIM VCT PLC (The 'Company') 31 October...

PETALUMA, CA--(Marketwire - Oct 31, 2012) - The following is a statement by the American Small Business League: Tuesday, President Obama reiterated his administration's plans to combine the...

BioMarin to Make $5 Million Strategic Equity Investment in Catalyst  Catalyst Licenses North American Rights to Firdapse™, a Phase III Orphan Drug for the Treatment of Lambert-Eaton...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Résultats consolidés des neuf premiers mois 2012 ...

Copenhagen, 2012-10-31 13:02 CET (GLOBE NEWSWIRE) --   ISS A/S will publish its Interim Report for Q3 2012 on Wednesday 7 November 2012.  The Interim Report and investor presentation...

Company Announcement - Arzerra worldwide net sales in Q3 2012 totaled GBP 18.2 million - Genmab expects royalty payment of DKK 34 million Copenhagen, Denmark; October 31, 2012 – Genmab A/S...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ALBION TECHNOLOGY & GENERAL VCT PLCNOTIFICATION OF...

ETTEPLAN OYJ INTERIM REPORT OCTOBER 31, 2012 AT 02:00 P.M. ETTEPLAN Q3: Steady development in uncertain market conditions Review period July-September 2012 - The Group’s revenue grew by 9.5%...